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INTRODUCTION 
Aspergillus is a genus that consists the largest number of mold species. There are 
numerous plant-, animal-, and human pathogens (Aspergillus fumigatus, Aspergillus terreus, 
Aspergillus lentulus, Aspergillus flavus, Aspergillus niger, Aspergillus nidulans) among them. 
Recently invasive mold diseases rank among diseases with the highest morbidity and 
mortality in the developed countries. Their prevalence shows a gradually increasing tendency. 
Literature data estimate that at least as many, if not more, people die from invasive fungal 
diseases than malaria or tuberculosis.  
The mortality rate can be as high as 100%. Literature data report that in certain patient 
groups every single hour spent without adequate antimicrobial therapy significantly increases 
the mortality. According to hospital statistics in the European population, Aspergillus 
fumigatus is responsible for about 7% of all hospital mortalities. Recently the occurrence of 
invasive mold infections caused by Aspergillus terreus species increased significantly as well.  
Along with Candida species, Aspergilli provoke most frequently different nosocomial 
fungal infections. People with certain immunodeficiency, especially those with severe 
haematological problems (neutrophil count <500 x 10
6
/liter) belong to the risk group. People 
suffering from acute myeloid leukaemia (AML) have the highest chance to develop disease. 
Since fungal diseases notably affect the life span, and the quality of life of people in 
the haemato-oncology wards, the hospital infection-control has gained more importance.  
Settling an adequate diagnosis is hard. Verification of the presence of fungi in the 
attacked tissues is possible only after time consuming culturing or histopathological 
techniques, requiring invasive procedures (broncho-alveolar lavage sampling; BAL). 
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Serology unlike culturing techniques can provide results within three hours. These 
methods detect unique but general fungal cell wall constituents, and are not suitable to detect 
the causative agents on species specific level. Combination testing with other methods 
screening for biomarkers (more often PCR) is crucial.  
Recently, the nucleic acid based screening methods in virtue of their rapid and easy 
workflow, and good reproducibility are more popular and fancy. Validated PCR methods are 
able to detect Aspergilli also on species specific level.  
Given by the presence of ubiquitous pathogenic agents however, highly sensitive 
PCRs can lead to false-positives and very low specificity. The extraordinary high false-
positive rates of serological procedures can be observed among patients being treated 
immediately before diagnosis with Piperacillin-Tazobactam, Ampicillin-Sulbactam and 
Amoxicillin-Clavulanic Acide beta-lactame type antibiotics and with the combination of beta-
lactamase inhibitors and other antibiotics (PenicillinG, Ceftriaxon, Imipenem, Ciprofloxacin, 
Vancomicin, Gentamicin, e.g.).  
The ISHAM (International Society for Human and Animal Mycology) - EAPCRI 
(European Aspergilllus PCR Initiative) is a non-profit organisation whose members are 
engaged to collaborate and develop a standard for Aspergillus PCR methodology and to 
validate different in-house methodologies in clinical trials so that PCR could be incorporated 
into future consensus definitions for diagnosing invasive fungal infections (IFIs).  
The members of the laboratory working party meet in every 2-3 years, analyse the 
results of former executed studies, design further international cooperations and identify the 
most important variables that influence the performance of PCR. The goal of the clinical 
working party is to analyse and summarize the novel issues of the laboratory and statistical 
working party in cooperation with the two other academic groups; EBMT (European Society 
for Blood and Marrow Transplantation), and EORTC (European Organisation for Research 
and Treatment of Cancer).  
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The apathogen, saprophytic Gram-positive Streptomyces bacteria belong to the 
phylum Actinobacteria and to the order Actinomycetales composing about 20% of the normal 
soil bacterial population and sharing common ecological niche with the former mentioned 
Aspergilli. Their growth comprises complex morphological and biochemical processes 
representing remarkable differences in liquid and on solid medium. Their complex life cycle 
is regulated by pleiotropic auto-regulators. One of them is Factor C. 
Investigation of the regulatory roles of Factor C - which is up to now the only one 
known auto-regulator protein - was commenced at the University of Debrecen (UD), Institute 
of Biology (recently UD, Department of Human Genetics) after its isolation, identification, 
cloning and sequencing from the 72 hours old liquid fermentation of the producer strain 
Streptomyces griseus 45H (according to the new nomenclature S. albidoflavus 45H). The 
secreted protein constitutes 324 amino acids.  
By using the amino acid sequence of the mature Factor C protein PSI-BLAST 
(Position-Specific Iterative Basic Local Alignment Search Tool) sequence homology search 
algorithm was used to find similar (orthologous) proteins in other species. In this wise we 
found similar proteins in four human pathogenic filamentous fungal species, in further two 
apathogen fungi, in certain other Streptomyces species, and in certain Gram-positive, not 
Actinomyces type, low G+C bacteria, and in their phages respectively.  
Based on sequence data of the pathogenic filamentous fungal species facC gene could 
be found only in Aspergillus fumigatus and Aspergillus terreus. Based on our own research 
data the genome Aspergillus lentulus - which is still not sequenced - possesses facC genes as 
well. Moreover, in the genome of Aspergillus fumigatus facC genes can be found on two 
chromosomes Chr#3 and Chr#5 respectively. 
The presence of facC orthologous genes could only be affirmed in the genomes of 
eukaryotic, human pathogenic species known as primary causative agents of invasive 
aspergillosis, furthermore are not present in the genomes of species possible present in the 
blood stream of immunocompromised hosts colonizing and evoking systemic infections 
(bacterial and fungal). Based on these facts it was a great opportunity for us to develop 
nucleic acid based assays detecting these unique facC orthologous genes. 
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OBJECTIVES 
 To develop real-time assays to diagnose invasive aspergillosis based on the presence 
of the facC orthologous genes of the major causative agents of Aspergillus fumigatus, 
Aspergillus terreus, and Aspergillus lentulus. 
 To determine the reaction efficiency, analytical sensitivity and analytical specificity of 
our Aspergillus fumigatus and Aspergillus terreus specific Taqman® assays. 
 Identification of Aspergillus fumigatus and Aspergillus lentulus species based on their 
specific melting points (melting analysis) and melting curves (HRM analysis). 
 To estimate the dynamic ranges of our Taqman® assays in automatic nucleic acid 
extraction system and on large number serum samples spiked with Aspergillus 
fumigatus and Aspergillus terreus conidia. 
 To validate of our Taqman®-LNA3 real-time assay in a prospective case-control study 
at the University of Debrecen in collaboration with the Department of Internal 
Medicine, Institute of Medical Microbiology and Institute of Pathology. To perform 
combined biomarker testing and to monitor episodes with neutropenic fever for the 
presence of Aspergillus specific antigenes (galactomannan) and for the presence of 
Aspergillus fumigatus facC orthologous genes on three consecutive days. We compare 
the results of biomarker analyses with each other and with those of conventional 
methods and estimate the diagnostic efficiency of every single method. 
 To participate in annual cross-control studies in order to test and improve our in-house 
real-time assays and to estimate our performance as compared to those of the other 
groups. 
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MATERIALS AND METHODS 
Bioinformatic methods screening for Factor C homologs 
We searched databases with the PSI-BLAST for the presence of homologous amino 
acid sequences of the mature Factor C protein. 
Developing of Taqman
® 
MGB and Taqman
® 
LNA assays 
We developed eight different Taqman® hydrolysis assays (4 Taqman®-MGB and 4 
Taqman®-LNA assays) for the detection and identification of Aspergillus fumigatus and 
Aspergillus terreus species. In the case of our different mono-copy systems there is only one 
target sequence available. Since in the Aspergillus fumigatus genome there are two facC 
orthologous genes present (AFUA_3G14910, AFUA_5G00540) we developed dual-copy 
assays as well. In this case we run two simultaneous PCR amplifications using different target 
sequences (duplex PCR) involving the usage of four different sequence specific primers and 
two different probes labeled with the same fluorophore dye in one tube. 
Cultivation of Aspergillus strains and purification of the gDNAs 
As making inoculums we used the spore suspensions of three (Aspergillus fumigatus 
AF293) and seven days old (Aspergillus terreus NCCB IH2624 and Aspergillus lentulus 
SZMC3118) cultures and we let them grow on liquid, glucose containing minimal medium. 
Mechanical lysis was performed with liquid nitrogen and than we purified the gDNA (Thermo 
Scientific, Maryland, USA) according to manufacturer’s instructions. 
PCR amplification controls 
The term genomic equivalent (GE) is equivalent with the amount of genomic DNA 
present in one cell. We incorporated appropriate internal amplification controls within every 
single run protocol during the real-time analyses of the samples with different Aspergillus 
fumigatus, Aspergillus terreus and Aspergillus lentulus gDNA contents (10
2
-10
3
 GE).  
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Determination the reaction efficiency and specificity of the Taqman
® 
MGB and 
Taqman
® 
LNA assays on gDNA panels 
After construction of standard series (panels) from the gDNA isolates of filamentous 
fungi we estimated the reaction efficiency, limit of detection (LoD) and the linear dynamic 
range of every single assay. We used 25-member serial dilution panels across 7 orders of 
magnitude (15 ng - 15 fg) by using the gDNAs of Aspergillus fumigatus AF293, Aspergillus 
terreus NCCB IH2624 strains and nuclease free water (Ambion PCR grade water). We run 
every sample in triplicate. For the graphical representation of the standard curves after the 
successful PCR amplification reactions mean Cp values of the triplicates were taken and 
plotted as a function of the log10 input values of genomic contents (GEs). In order fit the data 
to a straight regression line, we used the slopes of these regression lines (y = mx + b) and we 
calculated the reaction efficiency values.  
We investigated the specificity of our Taqman®-MGB assays on human DNA and on 
numerous pathogenic and apathogenic fungal gDNA samples respectively. The specificity of 
our Taqman®-LNA4 assay was investigated on the ISHAM-EAPCRI panel performed and 
released in the year of 2013 (2013/08/20).  
Melting point analysis for the detection of Aspergillus fumigatus and Aspergillus lentulus 
species 
After evaluating the results of the 2013/08/20 ISHAM-EAPCRI cross-control panel 
we observed that our Aspergillus fumigatus specific Taqman®-LNA3 assay cross reacts with 
the gDNA of Aspergillus lentulus. From these facts we concluded that the genome of 
Aspergillus lentulus (whose genome is still not sequenced) may also contain facC alike 
orthologous gene. We designed primers for the amplification of Aspergillus fumigatus 
AFUA_3G14910 and AFUA_5G00540 genes and using Aspergillus fumigatus Af293 gDNA 
as template and we optimized the reaction parameters. Using the same primers under the same 
reaction conditions we successfully amplified facC like fragments on Aspergillus lentulus 
SZMC3118 purified gDNA template as well. After sequencing these facC amplicons of 
Aspergillus lentulus origin we designed PCR primers matching to facC alike genes present of 
both species; Aspergillus fumigatus Af293 and Aspergillus lentulus SZMC3118 to 
differentiate among them on the basis of the different melting curves (HRM analysis) of their 
templates. 
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Measuring the reaction efficiency of facC-HRM assays on gDNA panels 
We constructed Aspergillus fumigatus AF293 and Aspergillus lentulus SZMC3118 
gDNA panels (Afu-HRM panel-1, Alent-HRM panel-2, Afu-Alent-HRM panel-3) on 7-fold 
dilution series (10
6
-1 GE/PCR reaction). 
Measuring the dynamic ranges of our Taqman
® 
assays on conidia panels 
The fungal nucleic acid purification of biological samples was done in a Roche 
MagNA Pure LC 2.0 robotic system. We performed 6-membered whole blood panels across 6 
orders of magnitude (10
6
-10
1
) to determine the dynamic ranges of our Taqman®-MGB 
(Taqman®-MGB3, Taqman®-MGB4), and Taqman®-LNA (Taqman®-LNA3, Taqman®-
LNA4) assays. After these we further investigated our Taqman®-LNA assays on 5-membered 
serum panels across 4 orders of magnitude (10
1
-10
4
). 
According to our extraction run protocols we also analysed negative control samples 
in accordance with those containing of fungal conidia in different amounts. 5% positivity of 
the extraction negative control samples resulted in a disapproval of the extraction run results. 
Fungal conidia were disrupted with MagNA Lyser Instrument (Roche Applied 
Science) and ceramic beads according to our optimized protocol (ceramic bead-beating) in 
250 µl and in 1250 µl sample volumes respectively.  
We ran the Taqman®-MGB real-time PCR amplification reactions on Applied 
Biosystems 7500 Real-Time PCR, while the Taqman
®
-LNA real-time assays ran on a Roche 
LightCycler
® 
480 Instrument II in 20 µl reaction volumes by the incorporation of adequate 
PCR-internal controls and PCR-NTCs. 
The 2014 ISHAM-EAPCRI BAL panels 
In November of 2014 we investigated the cross-control panels released by the 
ISHAM-EAPCRI international organisation. For measuring the analytical sensitivity of the 
different home developed and optimized real-time diagnostic methods there were guinea pig 
BAL samples made in the Cardiff central microbiology laboratory of the organisation. 
We received two identical BAL panels (BAL panel-D1, BAL panel-D2) for 
investigation. In one case the Aspergillus fumigatus fungal nucleic acids were extracted in a 
robotic system from the BAL samples while in the other case we purified the nucleic acid on a 
manual platform. 
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We performed mechanical lysis in every cases in order to extract the fungal nucleic 
acids from the BAL samples. We investigated the two BAL panels in different real-time 
systems (Roche LC 2.0, LC 96). We tested all together 4 different methods (method-1, -2, -3, 
-4). 
In the case of method-1 and method-2 the volume of the samples (250 µl), the 
mechanical lysis protocol (ceramic bead-beating) and the robotic sample extraction platforms 
(Roche MagNA Pure LC 2.0) were identical. It was only the real-time platform that differed. 
In the case of the method-1 we ran the samples in Roche LC 2.0 capillary PCR system while 
in the case of the method-2 samples ran in Roche LC 96 well plate system. 
Method-3 was identical with the method-1 but the mechanical lysis procedure. In the 
case of method-3 we applied the Roche SeptiFast Lysis Kit according to manufacturer’s 
instructions. 
Method-4 substantially differed from the above presented. In the case of this latter the 
template volume was 2,5 times as much compared to the formers and the BAL panel-D2 was 
only analysed with this latter. Fungal cell wall extraction was according to our optimized 
bead-beating protocol followed by manual DNA extraction. According to this we settled the 
elution volume to 45 µl which was completely monitored during post-elution in Roche LC 2.0 
capillary system. 
Results were scored as follows: three points for detecting an essential sample (≧10 
CFU/GE for fungal DNA containing samples and 0 CFU/GE in the case of negative control 
samples) and two points for detecting a desirable (<10 CFU/GE) sample. The maximum score 
achievable was 32 (24 for essential samples and 8 for desirable), for the separate detection of 
conidia or DNA the maximum score is 16, respectively.  
The maximum score achievable for analysing Aspergillus fumigatus conidium and 
Aspergillus fumigatus DNA panels was 16-16 for each.  
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PATIENTS AND METHODS 
Study population 
Between June 06, 2012 and May 08, 2013, 27 febrile neutropenia episodes (FNEs); 16 
males with the median age (yr) ±(SD) of 42.5 ±21.72, (range; 14-75), and 11 females with the 
median age (yr)±(SD) of 45.5 ±15.31, (range; 19-66) with different haematological 
malignancies (mainly acute leukemias) receiving stem cell transplantation and intensive 
chemotherapy were included at the onset of febrile neutropenia (neutrophil count < 0.5x10
9
 
cells/L; temperature > 38°C recorded twice or > 38.5°C recorded once) in our local 
prospective case-control study in cooperation with the Institute of Internal Medicine of the 
University of Debrecen. 
Case group, control group 
On the basis of serological, radiological, microbiological, and histological data signs 
and symptoms of IPA were collected together along with host criteria and episodes were 
retrospectively stratified according to revised European Organization for the Research and 
Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria in order to define case-
group of “proven” or “probable” IPA (7 patients) and control-group “possible” IPA (20 
patients with no EORTC/MSG evidence of IA). 
Diagnostic strategy of invasive pulmonary aspergillosis 
At the onset of fever broad-spectrum antibiotic treatment (e.g., (pl. cefepime, 
carbapenem) was administered according to the published IDSA (Infectious Diseases Society 
of America) guidelines. Standard chest CT radiology was invariably performed and BAL 
analysis was performed as clinically indicated. 
Furthermore, for FNE, combined biomarker testing was commenced. Serum samples 
were prospectively screened for the presence of genus and species specific biomarkers (GM 
and facC genes) with Platelia Aspergillus GM-enzyme immunoassay and facC-PCR. 
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Consecutive serum samples (3 x 3 ml) were routinely piped together with clinical test 
request formulas of the episodes from the onset of febrile neutropenia to the Department of 
Medical Microbiology, Debrecen, Hungary for GM antigen monitoring. 
Screening for GM-antigenemia a sandwich ELISA test (Platelia Aspergillus GM-EIA; 
Bio-Rad Laboratories, Hungary) was used according to the developer’s instructions. GM-EIA 
cutoff values were determined using the OD450/620 value of sample / OD450/620 value of control. 
While evaluating single specimens any value above the OD450/620 ≧ 0.5 cutoff value was 
considered positive as requested for in vitro testing. 
In parallel with GM-serology we performed facC orthologous genes based nucleic 
acid diagnosis as well (facC-PCR) at the Department of Human Genetics. In this study there 
were triplicate facC-PCR reactions were performed pro specimens. In a triplicate on the basis 
of a single positive PCR the specimen was considered PCR positive. In optimal cases there 
were three GM-EIA and three facC-PCR results assigned to every single episode. 
In the case of fever refractory to broad spectrum antibiotic treatment, and/or positive 
GM-serology, and/or positive chest CT there were BAL examinations also performed. 
When performing postmortem analysis Hematoxylin and Eosin (H&E) staining is able 
to visualize the fungal hyphaes in lung parenchyma but in the case of tissue necrosis further 
supplementary staining procedures like as Grocott-Gömöri methenamine silver staining 
(GMS) and/or the Periodic Acid-Schiff (PAS) staining are suggested to perform. Lung 
sampling was performed from three independent parts of the potentially infiltrated lung 
parenchyma and carefully examined for the presence of fungal filaments of Aspergillus origin. 
Therapeutic strategy of invasive pulmonary aspergillosis 
Recurrent or persistent fever refractory to broad spectrum antibiotic treatment, 
concomitant positive (more than one) GM-serology result along with either positive CT 
and/or positive BAL was considered sufficient evidence to initiate broad spectrum antifungal 
treatment. In the case of ceased fever, negative chest CT and/or BAL we suggest to extend the 
combined biomarker monitoring two times on a weekly basis. 
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DATA INTERPRETATION 
Patients enrolled in statistical analyses were subclassified into two groups (cases and 
controls) according to the disease investigated (proven, probable aspergillosis) and their 
actual health profile. Along with estimating the categorical (positive test result/presence of the 
disease, negative test result/absence of the disease) and continuous (Se, Sp, PV
+
, PV
-
) 
variables we calculated mean, median values, standard deviation (SD±) and confidence 
intervals (95% CI) as well. 
ROC analysis 
To measure the diagnostic accuracy of the two screening tests results from GM-EIA 
and facC-PCR testing (77 GM-EIA indexes and 249 facC-PCR Cq values) were converted to 
qualitative (positive, negative) indexes considering the presence (cases) or absence (controls) 
of IPA infection of the episodes providing the biological samples. 
In the case of facC-PCR every single run was evaluated independently. After 
calculating the series of sensitivity (Se) and specificity (Sp) reports at every single decision 
threshold the receiver operating characteristic (ROC) curve was edited by plotting the true 
positive values (sensitivity values on y- axis) versus the false positive rates (1-specificity 
values on x-axis). Area under the ROC curve (AUC) was estimated with 95 % confidence 
intervals (95 % CIs) and with standard errors (±SD). Along with these we also calculated 
positive and negative likelihood ratios (LR
+
, LR
-
) and positive and negative predictive values 
(PV
+
, PV
-
) as well. 
Comparison of the two classifiers with Kappa-test 
Cohen’s Kappa test was used for assessing sample concordance between the two 
raters; the gold-standard (Platelia Aspergillus GM-EIA) and the new method being tested 
(facC-PCR). Categorical (qualitative) outcomes of the screening methods were compared with 
no regard to patient statuses estimating the agreement occurring by chance. 
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RESULTS 
We confirmed the presence of facC orthologous genes in human pathogen species 
causing aspergillosis 
When searching databases with the amino acid sequence of the mature Factor C 
protein with PSI-BLAST sequence homology search algorithm we found facC alike 
orthologous genes, presumably with the same evolutionary origin in the genomes of the 
human pathogen filamentous strains of Aspergillus fumigatus Af293, Aspergillus terreus 
NIH2624 among others. In the genome of Aspergillus fumigatus Af293 there are two copies 
of the gene. One is on the Chr#3 (AFUA_3G14910) and the other is on the Chr#5 
(AFUA_5G00540). In the genome of Aspergillus terreus IH2624 there is only one copy of the 
facC gene. 
Dynamic ranges of the Taqman®-MGB and Taqman®-LNA assays on gDNA panels 
We developed and tested eight different Taqman® assays for the specific detection 
and identification of the species Aspergillus fumigatus (MGB1, MGB2, MGB3, LNA1, 
LNA2, LNA3) and Aspergillus terreus (MGB4, LNA4). Whit this we assessed on Aspergillus 
fumigatus Af293 and Aspergillus terreus IH2624 gDNA panels the reaction efficiencies and 
limit of detection values (LoD) of our real-time assays. Based on our results we concluded 
that the Taqman®-LNA3 assay proved to have the highest sensitivity to detect Aspergillus 
fumigatus Af293 (LoD = 1 GE), while Taqman®-LNA4 assay was the most sensitive in 
detection of Aspergillus terreus IH2624 (LoD = 1 GE) species. 
Analytical specificity of Taqman®-MGB and Taqman®-LNA assays on gDNA panels 
We proved experimentally that Taqman®-MGB hydrolysis assays (Taqman®-MGB3, 
Taqman®-MGB4) hybridizing to certain regions of facC orthologous genes present in 
Aspergillus fumigatus Af293 and Aspergillus terreus IH2624 genomes do not cross react with 
each other or with numerous other species possessing facC orthologous counterparts. We 
examined the analytical specificity of our Aspergillus fumigatus specific Taqman®-LNA3 
and our Aspergillus terreus specific Taqman®-LNA4 assay on the ISHAM-EAPCRI 2013 
panel. According to this our Aspergillus fumigatus and Aspergillus terreus specific assays did 
not cross react with each other nor with the gDNA of several species with one exception only. 
Interestingly our Aspergillus fumigatus specific Taqman®-LNA3 assay cross reacted with the 
gDNA of Aspergillus lentulus. 
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Diagnostic accuracy of facC-HRM assay on Aspergillus fumigatus and Aspergillus 
lentulus gDNA panels 
We proved the presence of two Aspergillus fumigatus facC alike and presumably 
Streptomyces facC orthologous genes in the genome of Aspergillus lentulus SZMC3118 
species being also similar in size (900-950 bp) to the ancestor gene. The genes were first 
amplified and than sequenced with sequence specific primers designed to the 
AFUA_3G14910 and AFUA_5G00540 facC orthologous genes present in Aspergillus 
fumigatus genome. Using the sequence data, we successfully engineered primers for the 
sensitive detection and identification of Aspergillus fumigatus Af293 and Aspergillus lentulus 
SZMC3118 strains on the basis of the characteristic melting points of their amplicons. After 
performing Aspergillus fumigatus Af293 and Aspergillus lentulus SZMC3118 gDNA panels 
we estimated the diagnostic accuracy, amplification efficiency, the limit of detection of our 
facC-HRM assay and the characteristic melting points of the different amplicons for the 
specific identification of the species. 
Diagnostic accuracy of Taqman® assays on Aspergillus conidia containing blood panels 
When performing linear regression analysis, we assessed the dynamic ranges of our 
Aspergillus fumigatus (Taqman®-MGB3, Taqman®-LNA3) and Aspergillus terreus 
(Taqman®-MGB4, Taqman®-LNA4) specific real-time assays on whole blood and serum 
samples containing different amounts of fungal conidia. On the basis of our data we 
concluded that the amplification efficiency proved to be better in the case of Taqman®-LNA 
hydrolysis assays as their amplification efficiency data fall into the optimal range (E = 103-
107%) when testing whole blood samples. Moreover, both our Taqman®-LNA3 and 
Taqman®-LNA4 assays were able to detect single Aspergillus fumigatus and Aspergillus 
terreus conidia (LoD = 1 GE) in biological samples. Therefore, we further tested the 
diagnostic utility and dynamic range of our Taqman®-LNA assays on large number of serum 
samples. The reaction efficiency of our Taqman®-LNA3 real-time assay on large volume, 
conidia containing serum samples was 117,54%, while for the Taqman®-LNA4 assay it was 
107,93%. 
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Infection control of invasive pulmonary aspergillosis (IPA) 
Case group, control group 
During the one-year follow-up period there were 27 episodes enrolled in our case-
control study. Episodes were retrospectively stratified according to revised European 
Organization for the Research and Treatment of Cancer/Mycosis Study Group 
(EORTC/MSG) criteria in order to define a case-group of “proven” or “probable” IPA and a 
control-group possible IPA  
Empiric antifungal therapy 
There were 15 patients with neutropenic fever receiving antifungal treatment. Later it 
was proved however that 60% of these patients were loaded unnecessary with the side-effects 
of strong cito- and hepatotoxic agents. 
Diagnosis of IPA with conventional methods 
Concordant negative Aspergillus GM and negative CT supported by PCR have been 
shown to have the highest discriminatory power to exclude IPA. Their results proved to be 
concordant in 94,5% of the cases not supporting IPA. The negative predictive value of the two 
methods was; PV
-
: 0,94. Invasive BAL procedure was performed in 77% of episodes when 
indicated. Concordant negative chest CT and BAL results showed high discriminatory power 
to exclude IPA; PV
-
: 0,92. Based on our results we determined that the invasive BAL 
procedure have a strong capacity (PV
-
: 0,93) to prove the absence of invasive aspergillosis in 
93% of the controls investigated (15 people) which means that there was only one patient that 
was misdiagnosed. 
Diagnostic accuracy and diagnostic utility of the biomarker-screening assays 
We performed ROC (receiver operating characteristic curves) analysis and area under 
the ROC curve (AUC) was estimated for both classifiers; Platelia Aspergillus-EIA and facC-
PCR. The area under the ROC-curve (AUC) for Aspergillus GM-EIA was 0.7283 (95% CI 
0.6031-0.8535); P value of < 0.0012 ±0.0639 representing a „fair” agreement while that for 
the facC-PCR was 0.8004 (95% CI 0.6976-0.9031); P value of < 0.0001 ±0.05243 
representing a „good” agreement. 
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Diagnostic performance parameters were calculated (by doing the 2x2 contingency 
tables of cases and controls); sensitivity (Se) values, specificity (Sp) values, discriminatory 
properties of post-test probabilities (likelihood ratios; LR
+
, LR
-
), predictive values (PV
+
, PV
-
) 
and accuracy indexes (DORs) with 95% confidence intervals (95% CI) for GM screening 
(GM-EIA) and for the nucleic acid based diagnostic method (facC-PCR) respectively.  
Sample concordance was assessed between the two classifiers; Platelia Aspergillus 
GM-EIA and facC-PCR showing a fair agreement generating an observed ratio of 47.17% and 
a Cohen kappa statistic of 0.258. 
Mortality data 
The overall mortality rate of our case-control study was 48.14%. 13 of 27 patients died 
during the surveillance period. 43.47% of patients died from the GM-EIA negative and 75% 
of the patients from the GM-EIA positive group. 
Case-studies 
Post-mortem histology (PMH) was performed in 53.85% (7/13) of episodes. There 
were major discrepancies observed between clinical and post-mortem findings in the case of 
two episodes. 
Autopsy proved hyphal tissue invasion in the case of one patient only (patient ID 4). 
Interestingly this patient with ceased fever in response to antibiotic treatment provided 
negative CT result along with 7 consecutive negative GM-EIA indexes but successively 
positive PCRs generating 10 runs of 11 that were positive thus was classified “possible” and 
remained undiagnosed. This patient was shown unequivocally only at autopsy to have IA. The 
presence of fungal hyphal invasion in the lung tissue was confirmed by PAS and H&E 
staining and the episode was subsequently classified “proven” 
One patient (patient ID 24) was originally classified “probable” based on positive 
thoracic CT and GM-EIA but definite negative PCRs. As post-mortem histology could not 
demonstrate fungal involvement, episode was reclassified “possible”. 
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DISCUSSION 
The fact that prokaryotic facC orthologous genes have been passed from different 
prokaryotic Streptomyces to eukaryotic, human pathogen, filamentous fungal strains served 
the basic concept of this PhD thesis. 
It was proved experimentally that out of fungal strains colonizing immunosuppressed 
patients and provoking systemic fungal infections (so their biological markers can be 
attainable in the human blood) only the Aspergillus fumigatus, Aspergillus terreus, and 
Aspergillus lentulus possess facC orthologous genes. Based on the level of the sequence 
divergence attainable among these genes we were able to design specific assays hybridizing to 
certain regions of these genes that are neither cross reacting with each other nor with other 
strains allowing us to detect them specifically and with high sensitivity in different biological 
samples (whole blood, serum and BAL). 
We developed eight different Taqman® real-time, and one HRM assay. Based on our 
data the LoD values of the Aspergillus fumigatus specific Taqman®-LNA3, and the 
Aspergillus terreus specific Taqman®-LNA4 real-time assays proved to be low (LoD = 1 
CFU/biological sample) on different gDNA panels. The validation of our HRM assay 
identifying Aspergillus fumigatus and Aspergillus lentulus based on their melting curves of 
their amplicons is still in progress. The analytical sensitivity of the assay on different 
Aspergillus fumigatus, and Aspergillus lentulus gDNA panels; LoD = 1 GE. 
During the past few years we worked with serum, whole blood and BAL samples. We 
optimized numerous protocols depending on the different biological samples. For extracting 
whole blood and BAL samples the mechanical lysis protocol (performed with the Roche, 
MagNA Lyser Instrument) carried out by ceramic green beads proved to be the most 
effective. (method-1). Despite the fact that whole blood and BAL samples contain the highest 
amount of fungal nucleic acid molecules nowadays serum samples have gained more 
attention. 
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We also tested the analytical sensitivity of our real-time assays on the 2013 ISHAM-
EAPCRI panel. This panel contained different pathogen, invasive fungal infection (e.g., 
aspergillosis or candidiasis) causing gDNA isolates in different concentrations. Based on the 
results, the LoD value of Aspergillus terreus specific Taqman®-LNA4 assay proved to be 
very low. It was able to detect 18 fg (1,2 GE) gDNA form certain clinical isolates of 
Aspergillus terreus. 45% of the the other centres participating in the cross-control study were 
able to achieve this score (15 out of the other 33 participating centre). The specificity of the 
Taqman®-LNA4 assay was 100%. However, the Aspergillus fumigatus specific Taqman®-
LNA3 assay was not able to detect 1,2 GE gDNA of a certain Aspergillus fumigatus clinical 
isolates in 20 µl PCR reaction. 
As a member of the ISHAM-EAPCRI laboratory working party we participated in the 
examination of the 2014 BAL panels containing either Aspergillus fumigatus nucleic acids, or 
Aspergillus fumigatus conidia in different concentrations. After analysing the Aspergillus 
fumigatus BAL panels we estimated, that out of our four methods tested the highest score was 
achieved by the method-1 that is based on a mechanical lysis carried out by ceramic green 
beads and real-time detection in LC 2.0 capillary system (25 points out of 32). Furthermore, 
we estimated that our mechanical lysis protocol is able to disrupt the fungal cell wall without 
fracturing fungal DNA with ceramic green beads and extracting more efficiently Aspergillus 
fumigatus nucleic acids from BAL samples than the Septifast Lysis protocol. 
Prompt and accurate diagnosis is of high importance since hospital charges are 
increasing in a drastic manner in the course of disease. The hospital infection control and 
patient follow-up would be more effective in case of institutes had cost efficient routine 
diagnostic procedures allowing biological marker monitoring of patients. Based on the fact 
that patients suffering from different serious haematological malignancies (mainly acute 
leukaemia) with long lasting neutropenia are under highest risk developing invasive 
pulmonary aspergillosis hospital infection control gained importance. 
There was an aspergillosis surveillance group established at the University Hospitals 
of Debrecen comprising geneticists, molecular biologists, microbiologists and physicians, to 
assess the discriminatory power of combined biomarker testing by considering facC-PCR 
results together with those of the GM-EIA in our local patient population including patients 
with different hematological malignancies.  
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Patients were retrospectively categorized according to revised European Organization 
for the Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria in 
order to define a case-group of “proven” or “probable” IPA and a control-group “possible” 
IPA. 
As part of our diagnostic strategy combined biomarker testing (CBT) was commenced 
on the onset of neutropenic fever. Serum samples were prospectively screened for the 
presence of genus and species specific biomarkers galactomannan (GM) and facC genes 
(mean sample number: 3.11 ±2.36) on three consecutive days. 
We established that both CT and BAL screening have high negative predictive values 
(CT-PV
-
=0.85 and BAL-PV
-
=0.93), so according to our results they are rather suitable to 
exclude invasive pulmonary aspergillosis than to confirm it. After completing combined 
biomarker monitoring we established the diagnostic odds ratios of the biomarker screening 
tests. In the case of GM-EIA, DOR was 15.33, while in the case of facC-PCR it was 28,67. 
Finally, we think that our diagnostic method could be suitable for commercial use in a 
form of a diagnostic kit. The most optimal alternative would be a robotic, modular system. 
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SUMMARY 
The primary aim of this study was to develop PCR methods targeting facC 
orthologous genes for the sensitive detection of invasive aspergillosis in different biological 
samples. Accordingly, we developed eight Taqman® real-time assays (4 Taqman®-MGB and 
4 Taqman®-LNA) to specifically detect Aspergillus fumigatus and Aspergillus terreus species 
and one HRM assay to differentiate among Aspergillus fumigatus and Aspergillus lentulus 
based on the melting points of their amplicons. We evaluated the PCR amplification 
efficiency, sensitivity and the specificity of our assays on different genomic DNA panels 
made in-house and received from the ISHAM-EAPCRI core laboratory working party. We 
measured the diagnostic utility of our Taqman® real-time assays on biological samples; 
whole blood and serum spiked with different amounts of Aspergillus fumigatus and 
Aspergillus terreus conidia. Taqman®-LNA3 and Taqman®-LNA4 showed the lowest LoD 
values on whole blood samples therefore we measured their dynamic range on numerous 
serum samples. As a member of the ISHAM-EAPCRI laboratory working party we also 
participated with our in-house PCR platforms in international cross-control studies to identify 
the most important variables influencing the diagnostic performance of Aspergillus-PCR and 
collaborate with other members of the laboratory working party to validate a standard for 
Aspergillus-PCR methodology. Based on the results we can conclude that we were able to 
develop a very efficient mechanical lysis protocol to disrupt Aspergillus conidia without 
losing the freely floating nucleic acids from the biological samples and we can extract fungal 
nucleic acids from biological samples in both automated and manual platform with nearly 
100% efficiency. Our secondary aim was to validate the diagnostic power of our facC-PCR 
method and the gold-standard Aspergillus-GM serology diagnosing invasive pulmonary 
aspergillosis on large volume serum samples in patients with hematological malignancies and 
fevered neutropenia. Stratification correction followed by postmortem histology was done and 
according to this the diagnostic accuracy indexes (AUC for facC-PCR was 0.80 and for GM-
EIA was 0.73) and the diagnostic odds ratio of facC-PCR proved to be higher (DOR was 
28.67) compared to GM-EIA (DOR was 15.33). We also assessed the diagnostic value of 
standard clinical methods (CT and BAL) and compared to that of combined biomarker testing 
(Aspergillus GM-serology and facC-PCR) in our prospective case-control study. The 
observed agreement was 70.13% generating a kappa statistics of 0.258. With our results we 
demonstrated evidence that the consideration of standard clinical methods with combined 
biomarker testing can improve early and more accurate diagnostic decisions. 
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